Managing the Cost of C. difficile Infection with Novel Therapies:
Best Practices in Managed Care for Improved
Clinical and Economic Outcomes

A continuing medical education activity sponsored by NAMCP and AAMCN

This webinar series will provide critical updates on the advances in the management of C. Difficile Infection

These are archives of live webinars held between October 13, 2021 to October 15, 2021

If you participated in any of the live webinars, you are not eligible to claim credit from the archive of that webinar.

By clicking on each of the titles, you will be able to participate in each part.
It is not required that you participate in all.

These activities are valid from November 1, 2021 to November 1, 2023


This series is supported by an educational grant from
Merck


 
Audience: This activity is intended for healthcare professionals practicing in managed care environments.

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

Description:
The epidemiology and incidence of hospital- and community-acquired Clostridium difficile infection (CDI) has changed over the past decade resulting in increased cases of initial and recurrent infection. Up to 25% of patients with an initial episode of CDI experience disease recurrence. Recurrent CDI is particularly challenging to manage.

This webcast series will provide education on reducing the risk of recurrence, patient-specific risk factors for recurrent CDI, recommended and emerging treatments for recurrent CDI, and managed care considerations around the prevention and management of rCDI.


A Closer Look at the Prevention and Management of C. difficile Infection and Recurrence: Expert Perspectives for Improved Clinical and Economic Outcomes

  1. Examine the clinical burden of C. difficile infection, including recurrent infections
  2. Assess tools to identify patients who may be at increased risk for recurrent C. difficile infection
  3. Outline evidence-based approaches for the management of first and second recurrences of C. difficile infection in diverse patient populations
  4. Describe the role of available antimicrobial agents and biologics for treatment and prevention of recurrent C. difficile infection
  5. Apply recent evidence-based and expert consensus strategies for closing critical gaps in C. difficile infection care transitions and coordination
  6. Examine the recently updated IDSA and ACG clinical guidelines for the first-line management of CDI and guideline updates for prevention of CDI recurrence
       Physician, Nursing and CMCN credits valid to November 1, 2023

Managing the Cost of C. difficile Infection and Recurrence with Novel Therapies: Best Practices in Managed Care for Improved Clinical and Economic Outcomes

  1. Examine the economic burden of C. difficile infection, including recurrent infections
  2. Discuss recent efficacy and safety data on the treatment of CDI, including options to reduce recurrence
  3. Illustrate avoidable costs related to CDI treatment management that can impact benefit design and coverage decision-making
  4. Apply recent evidence-based and expert consensus strategies for closing critical gaps in C. difficile infection care transitions and coordination
  5. Examine the recently updated IDSA and ACG clinical guidelines and the effect of these changes on managed care professionals
       Physician, Nursing and CMCN credits valid to November 1, 2023